Literature DB >> 34095806

Virology features of a family cluster of SARS-CoV-2 infections in Shanghai, China.

Yanqiu Zhou1, Zheng Teng1, Hongyou Chen1, Xiaoxian Cui1, Fanghao Fang1, Jiabin Mou1, Hui Jiang1, Xi Zhang1.   

Abstract

The global spread of SARS-CoV-2 is currently continuing, and the World Health Organization has announced the risk assessment of the viruses as high. In this study, we analyzed virology features of SARS-CoV-2 causing a family cluster outbreak. Among the six family members, five have been laboratory-confirmed infection of SARS-CoV-2 viruses. A total of five SARS-CoV-2 viruses have been isolated from the nasopharyngeal swabs. The complete genome of the viruses exhibited 100% nucleotide identity with each other. Only two nucleotide differences have been observed between genomes of the isolated viruses and the HCoV/Wuhan/ IVDC-HB-01/2019 strain. Therefore, SARS-CoV-2 has been confirmed as the causation of the family cluster infections.
© 2021 Chinese Medical Association Publishing House. Published by Elsevier BV.

Entities:  

Keywords:  Family cluster; Full genome sequencing; Nasopharyngeal swab; SARS-CoV-2

Year:  2021        PMID: 34095806      PMCID: PMC8168300          DOI: 10.1016/j.bsheal.2021.05.003

Source DB:  PubMed          Journal:  Biosaf Health        ISSN: 2590-0536


Introduction

The coronavirus epidemic outbreak has currently caused great worldwide concern. Coronaviruses are single-strand, positive-sense RNA genomes ranging from 26 to 32 kilobases in length [1]. Coronaviruses can infect several birds and various mammals, including camels, bats, masked palm civets, mice, dogs, and cats [2], [3]. Coronavirus could cause different clinical diseases involving respiratory, enteric, hepatic, and neurological systems [4]. When infected, people exhibited mild clinical symptoms [1]. However, the severe acute respiratory syndrome coronavirus (SARS-CoV) and the Middle East respiratory syndrome coronavirus (MERS-CoV) have caused more than 8,000 human infections (916 fatalities) and 2,574 human cases (886 deaths) by the end of April 2021 respectively. (from WHO resource, accessed May 16, 2021 [5]). At the beginning of 2020, a new coronavirus was identified [6], [7], [8]. The virus has about 75%-80% homology to SARS-CoV, but divergent from MERS-CoV, wherefore it was named as SARS-CoV-2[9], [10]. As of May 16, 2021, China has reported 90,872 laboratory-confirmed cases of SARS-CoV-2 infection across 31 provinces and Xinjiang Production and Construction Corps, with 4,636 fatalities (The information is from the official website of the National Health Council, accessed May 16, 2021). In addition, 223 countries and regions throughout the world have reported a total of 162,177,376 SARS-CoV-2 human cases, with a fatality rate of 2.07% (from WHO Coronavirus Dashboard, accessed May 16, 2021 [11]). On January 19, 2020, the first SARS-CoV-2 case was reported in Shanghai. Up to May 16, 2021, a total of 2,038 cases with seven deaths have been documented in Shanghai (The information is from the official website of the Shanghai Municipal Health Commission, accessed May 16, 2021). This study reported epidemiologic features and virological characteristics of a family cluster of SARS-CoV-2 infections in Shanghai, China.

Case presentation

As field investigators and clinicians, we used a standardized surveillance reporting form to gather epidemiological and clinical data. Nasopharyngeal swabs and fecal samples were collected for viral isolation and other tests based on the Technical Guidelines for Laboratory Testing of Novel Coronavirus Pneumonia. The cluster in our study involved five confirmed COVID-19 cases and a timeline to illustrate the details (Fig. 1 ). The first patient (case A) was back in Shanghai from Wuhan on January 17. Two days later, he developed physical discomfort and fatigue but did not go to the hospital. His body temperature was average and with no pulmonary symptoms. On January 27, three other families (case B, C, D) members also developed fever and were laboratory confirmed as SARS-CoV-2 infection. On the following day, case E was home quarantine, together with a 3-year-old girl (the daughter of case E), till her confirmation to be infected with SARS-CoV-2 on the 18th day after the first patient's returning to Shanghai. However, the 3-year-old girl was negative for the SARS-CoV-2. Detailed epidemiological and clinical characteristics of the cases are described in Table1 .
Fig. 1

Schematic diagram of family dissemination and timeline of exposure to pre-symptomatic case and illness onsets of cases in Cluster of COVID-19 outbreak, Shanghai, China, 17 January – 4 February 2020 (n = 5).

Table 1

Detailed epidemiological and clinical characteristics of the cases and laboratory test results.

CategoryCase ACase BCase CCase DCase ECase F
RelationshipSon of case B and DFather of case A and CDaughter of case B and DMother of case A and CWife of case ADaughter of case A
Age (years)28552753273
SexMaleMaleFemaleFemaleFemaleFemale
Contact history with WuhanYes (business trip in Wuhan from Jan. 13 to 17)NoNoNoNoNo
Date of onsetJan. 19–20 (fatigue)Jan. 27Jan. 27Jan. 27Feb. 4Asymptomatic
SymptomNormal temperature and CTFeverFeverFeverFeverThe antibody test was negative
Date of admissionJan. 28Jan. 28Jan. 28Jan. 28Feb. 4
Presenting symptoms and signs
FeverYesYesYesYesYes
Body temperature (°C)37.538.738.238.538.6
CoughYes (dry)NoYes (dry)Yes (dry)Yes (dry)
CoryzaNoYes (mild)NoNoNo
Muscle sorenessYesYesNoYesNo
Imaging features of pneumonia yesYesYesYesYesYes
White blood cell count (×109 cells per L); (normal range 3·9–9·9)4.49×1098.80×1093.88×1095.79×1095.51×109
lymphocyte count (×109 cells per L);(normal range 1·1–3·6)0.91×1090.78×1090.94×1092.71×1090.85×109
SevereNoYesNoNoNo
Date of dischargeFeb. 7Feb. 4Mar. 3Feb. 24Feb. 22
Virological testing
Sample typeThroat swabThroat swabThroat swabThroat swabThroat swab
Collection dateJan. 28Jan. 28Jan. 28Jan. 28Feb. 4
Virus isolationYesYesYesYesYes
Sequence obtainedCompleteCompleteCompleteCompleteComplete
Schematic diagram of family dissemination and timeline of exposure to pre-symptomatic case and illness onsets of cases in Cluster of COVID-19 outbreak, Shanghai, China, 17 January – 4 February 2020 (n = 5). Detailed epidemiological and clinical characteristics of the cases and laboratory test results. The Ion Torrent S5 platform (ThermoFisher, Waltham, USA) was used for whole-genome sequencing with a mean read length of about 200 bp and at least 10,000 depth of sequence. Data analysis was predominantly conducted using CLC Genomics Workbench 7.5.1 software. Low-quality reads were trimmed using CLC trimmer, with a quality limit set at 0.05. The filtered reads were de novo-assembled in CLC under default parameters. Contigs with coverage over 10 were extracted and blasted against the Global Initiative on Sharing All Influenza Data (GISAID) databases. The phylogenetic and genetic characteristics of the SARS-CoV-2 genome sequences from the family cluster were analyzed. The alignment showed that viral nucleotide sequences of this cluster shared 100% sequence similarities. The genome of the five viral strains showed 99.99% nucleotide identities compared with that of SARS-CoV-2. Wuhan-Hu-1 reference strain (GenBank mn908947), and only two nucleotides were different, at site 8,782 and 28,144 of ORF1ab and ORF8, respectively. According to this molecular typing method, the five strains in our study were divided into S-lineage (nt8782T and nt28144C), which was the main epidemic type in the early stages of the outbreak. It is speculated that S-lineage might be an older type.

Discussion and conclusion

Although many studies have been performed to characterize the SARS-CoV-2 virus, including its basic biology, treatments, animal source and vaccines, and so on [12], [13], [14], [15], there are still many unknowns to be revealed. Wearing a mask and social distancing could break the transmission [16], [17], [18], [19]. This study analyzed the epidemiologic and virologic features of SARS-CoV-2 viruses isolated from a family cluster. Five in six members have been infected with SARS-CoV-2, except one 3-year-old girl. Neither virus nucleotide nor antibody has been detected from the girl. Due to the limit of evidence, we could not confirm why the girl was not infected. However, during the close contact tracing of these SARS-CoV-2 cases, personal protections, including masks and gloves, and the disinfection measures were well carried out for the girl to keep her away from the viral infections. Patients in our study had an incubation period of approximately 7–18 days. Case B, who was 55 years old, exhibited severe infections during hospitalization. The remaining four patients showed mild symptoms after infection, indicating that age might be an essential factor associated with the clinical outcome of SARS-CoV-2 conditions. Of note, fecal samples of case C have been continuously positive for SARS-CoV-2 viruses for 26 days. Although no SARS-CoV-2 virus has been isolated from any fecal samples, the long-term virus shedding via the intestine verifies the implementation of effective public health measures for disease prevention and control. In summary, our results highlighted the contribution of personal protection equipment in disease prevention and control. In the epidemiological investigation, the evidence provided by case reports was less persuasive than results of well-designed studies wherein information was obtained following a specified protocol. The whole-genome sequence evidence provided the basis for the reliability of the transmission of the cluster in our study. In addition, more attention should be paid to the fecal-oral transmission of SARS-CoV-2. Currently, limited knowledge is known for the SARS-CoV-2. More studies are urgently needed to prevent future epidemics of the virus.

Ethics statement

The experiments and protocols in this study were screened and approved by the Ethical Review Committee of the Shanghai Municipal Centre for Disease Control and Prevention (Shanghai CDC, ethical number: 2020-39). Clinical specimens were obtained from the routine surveillance programme of the Shanghai CDC. Sample collection was approved by either the patients or their parents with prior informed consent.
  17 in total

1.  Presenting Characteristics, Comorbidities, and Outcomes Among 5700 Patients Hospitalized With COVID-19 in the New York City Area.

Authors:  Safiya Richardson; Jamie S Hirsch; Mangala Narasimhan; James M Crawford; Thomas McGinn; Karina W Davidson; Douglas P Barnaby; Lance B Becker; John D Chelico; Stuart L Cohen; Jennifer Cookingham; Kevin Coppa; Michael A Diefenbach; Andrew J Dominello; Joan Duer-Hefele; Louise Falzon; Jordan Gitlin; Negin Hajizadeh; Tiffany G Harvin; David A Hirschwerk; Eun Ji Kim; Zachary M Kozel; Lyndonna M Marrast; Jazmin N Mogavero; Gabrielle A Osorio; Michael Qiu; Theodoros P Zanos
Journal:  JAMA       Date:  2020-05-26       Impact factor: 56.272

Review 2.  Coronavirus pathogenesis.

Authors:  Susan R Weiss; Julian L Leibowitz
Journal:  Adv Virus Res       Date:  2011       Impact factor: 9.937

3.  Industrial seafood systems in the immobilizing COVID-19 moment.

Authors:  Elizabeth Havice; Melissa Marschke; Peter Vandergeest
Journal:  Agric Human Values       Date:  2020-06-08       Impact factor: 3.295

4.  Covid 19: Transcending social distance.

Authors:  Anthony O'Brien
Journal:  J Psychiatr Ment Health Nurs       Date:  2020-06-28       Impact factor: 2.952

5.  The species Severe acute respiratory syndrome-related coronavirus: classifying 2019-nCoV and naming it SARS-CoV-2.

Authors: 
Journal:  Nat Microbiol       Date:  2020-03-02       Impact factor: 17.745

Review 6.  Endothelial dysfunction in COVID-19: a position paper of the ESC Working Group for Atherosclerosis and Vascular Biology, and the ESC Council of Basic Cardiovascular Science.

Authors:  Paul C Evans; G Ed Rainger; Justin C Mason; Tomasz J Guzik; Elena Osto; Zania Stamataki; Desley Neil; Imo E Hoefer; Maria Fragiadaki; Johannes Waltenberger; Christian Weber; Marie-Luce Bochaton-Piallat; Magnus Bäck
Journal:  Cardiovasc Res       Date:  2020-12-01       Impact factor: 13.081

7.  A Novel Coronavirus from Patients with Pneumonia in China, 2019.

Authors:  Na Zhu; Dingyu Zhang; Wenling Wang; Xingwang Li; Bo Yang; Jingdong Song; Xiang Zhao; Baoying Huang; Weifeng Shi; Roujian Lu; Peihua Niu; Faxian Zhan; Xuejun Ma; Dayan Wang; Wenbo Xu; Guizhen Wu; George F Gao; Wenjie Tan
Journal:  N Engl J Med       Date:  2020-01-24       Impact factor: 91.245

8.  Hand Hygiene, Mask-Wearing Behaviors and Its Associated Factors during the COVID-19 Epidemic: A Cross-Sectional Study among Primary School Students in Wuhan, China.

Authors:  Xuyu Chen; Li Ran; Qing Liu; Qikai Hu; Xueying Du; Xiaodong Tan
Journal:  Int J Environ Res Public Health       Date:  2020-04-22       Impact factor: 3.390

9.  HLA predictions from the bronchoalveolar lavage fluid and blood samples of eight COVID-19 patients at the pandemic onset.

Authors:  René L Warren; Inanç Birol
Journal:  Bioinformatics       Date:  2021-01-29       Impact factor: 6.937

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.